Addus HomeCare (NASDAQ:ADUS) Raised to Buy at StockNews.com

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS - Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday morning.

Other equities analysts also recently issued reports about the company. JMP Securities assumed coverage on Addus HomeCare in a report on Monday, December 16th. They set an "outperform" rating and a $150.00 price target for the company. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. Citizens Jmp upgraded shares of Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Macquarie reiterated an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Addus HomeCare presently has an average rating of "Buy" and an average price target of $134.22.

Addus HomeCare Price Performance

NASDAQ ADUS traded up $3.51 during trading hours on Friday, reaching $130.62. 132,235 shares of the company's stock traded hands, compared to its average volume of 138,989. The firm has a market cap of $2.37 billion, a PE ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.72. The firm has a 50-day simple moving average of $126.10 and a 200 day simple moving average of $126.96.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. During the same period in the previous year, the firm posted $1.03 EPS. The business's revenue for the quarter was up 7.1% compared to the same quarter last year. Sell-side analysts forecast that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 in the last ninety days. Insiders own 4.60% of the company's stock.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently modified their holdings of the stock. Quarry LP bought a new stake in Addus HomeCare during the third quarter valued at about $28,000. Farther Finance Advisors LLC raised its stake in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after acquiring an additional 366 shares during the period. KBC Group NV lifted its holdings in Addus HomeCare by 49.1% during the fourth quarter. KBC Group NV now owns 814 shares of the company's stock valued at $102,000 after purchasing an additional 268 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Addus HomeCare by 25.7% in the third quarter. GAMMA Investing LLC now owns 935 shares of the company's stock worth $124,000 after purchasing an additional 191 shares in the last quarter. Finally, Assetmark Inc. raised its position in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company's stock valued at $156,000 after purchasing an additional 121 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.